Tang, Daolin http://orcid.org/0000-0002-1903-6180
Kang, Rui
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA160417, R01CA229275, R01CA211070)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 19 October 2022
Revised: 3 November 2022
Accepted: 8 November 2022
First Online: 21 November 2022
Competing interests
: D.T. is an editorial board member of Cancer Gene Therapy. The authors declare no other conflicts of interest or financial interests.
Free to read: This content has been made available to all.